Loading...
Market
Will the mRNA cancer vaccine achieve 75-80% tumor reduction in trials by mid-2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Publication of clinical trial results in peer-reviewed journals or official statements from the Radiology Medical Research Center
Story
Russia to Launch Free mRNA Cancer Vaccine in 2025, Aiming for 75-80% Tumor Reduction
Dec 17, 2024, 05:27 PM
Russia has announced the development of a personalized cancer vaccine that will be provided to patients free of charge starting in 2025. The vaccine, developed by the Radiology Medical Research Center of the Russian Ministry of Health, is designed to treat cancer rather than prevent it. It aims to suppress tumor growth and reduce tumor size significantly, with preclinical trials showing a potential reduction of 75-80%. The vaccine's development was led by Andrey Kaprin, the General Director of the center, and involves mRNA technology, similar to that used in some Covid-19 vaccines. The cost to the state is estimated at 300,000 rubles per dose, but it will be free for patients.
View original story
Similar markets
Less than 50% • 25%
50% to 74% • 25%
75% to 80% • 25%
More than 80% • 25%
Less than 10,000 • 25%
10,000 to 50,000 • 25%
50,001 to 100,000 • 25%
More than 100,000 • 25%
No countries • 25%
1 to 5 countries • 25%
6 to 10 countries • 25%
More than 10 countries • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Significant survival improvement • 25%
Partial survival improvement • 25%
No significant change • 25%
Deterioration • 25%
Yes • 50%
No • 50%
